Jinchao Gu

Dr. Jinchao Gu

Neuroscience, Monash University, Melbourne, Victoria, Australia
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RHRiley Hall
Riley Hall
VSVallari Sawant
Vallari Sawant
JGJinchao Gu
Jinchao Gu
TSTim Sikora
Tim Sikora
BRBen N Rollo
Ben N Rollo
NBNicole J Van Bergen
Nicole J Van Bergen
The TRAPP (TRAnsport Protein Particle) protein complex is a multi-subunit complex involved in vesicular transport between intracellular compartments. The TRAPP complex plays an important role in endoplasmic reticulum-to-Golgi and Golgi-to-plasma membrane transport, as well as autophagy. TRAPP complexes comprise a core complex, TRAPPI, and the association of peripheral protein subunits to make two complexes, known as TRAPPII and TRAPPIII, which act as Guanine Nucleotide Exchange Factors (GEFs) of Rab11 and Rab1, respectively. Rab1 and Rab11 are GTPases that mediate cargo selection, packaging, and delivery during pre- and post-Golgi transport in the secretory pathway. Rab1 is also required for the first step of macroautophagy, a cellular recycling pathway. Pathogenic variants in genes encoding protein subunits of the TRAPP complex are associated with a range of rare but severe neurological, skeletal, and muscular disorders, collectively called TRAPPopathies. Disease-causing variants have been identified in multiple subunits of the TRAPP complex; however, little is known about the underlying disease mechanisms. In this review, we will provide an overview of the current knowledge surrounding disease-associated variants of the TRAPP complex subunits, propose new insights into the underlying disease pathology, and suggest future research directions into the underlying disease mechanisms.

24 December 2023 in Experimental Cell Research
Verified
Journal Article
Closed access
JGJinchao Gu
Jinchao Gu
BRBen Rollo
Ben Rollo
GBGeza Berecki
Geza Berecki
SPSteven Petrou
Steven Petrou
PKPatrick Kwan
Patrick Kwan
BCBrett Cromer
Brett Cromer

29 April 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
MMMadeline Frances Meli
Madeline Frances Meli
KSKristy Swiderski
Kristy Swiderski
JGJinchao Gu
Jinchao Gu
BRBen N Rollo
Ben N Rollo
BBBenjamin Grey Bartlett
Benjamin Grey Bartlett
BCBrett Cromer
Brett Cromer
The neuronal progenitor NG108-15 neuroblastoma x glioma cell line proliferates indefinitely in vitro and is capable of directed differentiation into cholinergic neurons. The cell line is a robust model for investigating neuronal differentiation and function in vitro. The lineage-specific transcription factor-mediated differentiation of pluripotent stem cell lines (PSCs) leads to more rapid, efficient, and functional neurons. In this study, we tested the hypothesis that transcription factors could also drive the fate of an immortalised cell line. We first established a stable NG108-15 cell line, by piggyBac (pBac) transposition, that conditionally expresses neurogenin-2 (Ngn2), a common transcription factor for specifying neuronal fate. Following doxycycline-induction of Ngn2, we observed more rapid and efficient differentiation, and improved neurite outgrowth and viability compared with the WT cell line. Moreover, when co-cultured with C2C12 mouse myotubes, the modified NG108-15 cells resulted in significantly larger acetylcholine receptor (AChR) aggregates, suggesting enhanced neuromuscular junction (NMJ) formation. These findings describe a novel methodology for differentiating NG108-15 cells more efficiently, to enhance the usefulness of the cell line as a motor neuron model.